SEC CIK 1755243
Chiplock Mark
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| AMRCview stock → | 2,815 | 2026-09-15 |
Position History — AMRC
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — AMRC
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-09-15 | Open-market sale | 476 | $22.46 | 2,815 |
| 2026-09-10 | Option exercise (derivative) | 1,625 | $0.00 | 3,375 |
| 2026-09-10 | Option exercise | 1,625 | $0.00 | 3,291 |
| 2026-03-12 | Open-market sale | 273 | $25.31 | 1,666 |
| 2026-03-10 | Option exercise (derivative) | 750 | $0.00 | 5,000 |
| 2026-03-10 | Grant / award (derivative) | 3,500 | $0.00 | 5,750 |
| 2026-03-10 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2026-03-10 | Option exercise | 750 | $0.00 | 1,939 |
| 2025-10-13 | Option exercise (derivative) | 11,799 | $0.00 | 5,899 |
| 2025-10-13 | Option exercise (derivative) | 5,000 | $0.00 | 0 |
| 2025-10-13 | Open-market sale | 5,000 | $44.92 | 1,189 |
| 2025-10-13 | Open-market sale | 6,599 | $41.92 | 6,189 |
| 2025-10-13 | Open-market sale | 5,200 | $41.57 | 12,788 |
| 2025-10-13 | Option exercise | 11,799 | $13.37 | 17,988 |
| 2025-10-13 | Option exercise | 5,000 | $12.35 | 6,189 |
| 2025-10-09 | Option exercise (derivative) | 5,000 | $0.00 | 5,000 |
| 2025-10-09 | Option exercise (derivative) | 2,100 | $0.00 | 17,698 |
| 2025-10-09 | Open-market sale | 7,100 | $39.97 | 1,189 |
| 2025-10-09 | Option exercise | 5,000 | $12.35 | 8,289 |
| 2025-10-09 | Option exercise | 2,100 | $13.37 | 3,289 |
| 2025-10-08 | Option exercise (derivative) | 3,800 | $0.00 | 19,798 |
| 2025-10-08 | Open-market sale | 3,800 | $39.75 | 1,189 |
| 2025-10-08 | Option exercise | 3,800 | $13.37 | 4,989 |
| 2025-10-07 | Option exercise (derivative) | 5,900 | $0.00 | 23,598 |
| 2025-10-07 | Open-market sale | 5,900 | $39.51 | 1,189 |
| 2025-10-07 | Option exercise | 5,900 | $13.37 | 7,089 |
| 2025-10-06 | Option exercise (derivative) | 5,900 | $0.00 | 29,498 |
| 2025-10-06 | Open-market sale | 5,900 | $38.92 | 1,189 |
| 2025-10-06 | Option exercise | 5,900 | $13.37 | 7,089 |
| 2025-10-01 | Option exercise (derivative) | 602 | $0.00 | 35,398 |
| 2025-10-01 | Option exercise (derivative) | 5,000 | $0.00 | 10,000 |
| 2025-10-01 | Open-market sale | 5,602 | $37.95 | 1,189 |
| 2025-10-01 | Option exercise | 602 | $13.37 | 6,791 |
| 2025-10-01 | Option exercise | 5,000 | $12.35 | 6,189 |
| 2025-09-15 | Open-market sale | 269 | $28.00 | 1,189 |
| 2025-09-10 | Option exercise (derivative) | 750 | $0.00 | 2,250 |
| 2025-09-10 | Option exercise | 750 | $0.00 | 1,458 |
| 2025-03-19 | Open-market sale | 95 | $11.92 | 708 |
| 2025-03-17 | Option exercise (derivative) | 276 | $0.00 | 3,000 |
| 2025-03-17 | Option exercise | 276 | $0.00 | 803 |
| 2025-03-10 | Grant / award (derivative) | 3,000 | $0.00 | 3,276 |
| 2024-09-19 | Open-market sale | 98 | $37.64 | 527 |
| 2024-09-17 | Option exercise (derivative) | 277 | $0.00 | 276 |
| 2024-09-17 | Option exercise | 277 | $0.00 | 625 |
| 2024-08-31 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2024-05-30 | Option exercise (derivative) | 3,000 | $0.00 | 0 |
| 2024-05-30 | Option exercise | 3,000 | $10.05 | 3,348 |
| 2024-05-30 | Open-market sale | 3,000 | $35.00 | 348 |
| 2024-03-19 | Open-market sale | 101 | $20.53 | 348 |
| 2024-03-17 | Option exercise (derivative) | 277 | $0.00 | 553 |
| 2024-03-17 | Option exercise | 277 | $0.00 | 449 |
| 2024-03-08 | Grant / award (derivative) | 20,000 | $0.00 | 20,000 |
| 2023-09-19 | Open-market sale | 105 | $43.51 | 172 |
| 2023-09-17 | Option exercise (derivative) | 277 | $0.00 | 830 |
| 2023-09-17 | Option exercise | 277 | $0.00 | 277 |
| 2023-03-17 | Grant / award (derivative) | 1,107 | $0.00 | 1,107 |
| 2022-03-10 | Option exercise (derivative) | 2,999 | $0.00 | 12,001 |
| 2022-03-10 | Open-market sale | 2,999 | $78.52 | 0 |
| 2022-03-10 | Option exercise | 2,999 | $43.00 | 2,999 |
| 2022-03-10 | Option exercise (derivative) | 2,999 | $0.00 | 12,001 |
| 2022-03-10 | Option exercise | 2,999 | $43.00 | 2,999 |
| 2022-03-10 | Open-market sale | 2,999 | $78.52 | 0 |
| 2022-03-08 | Option exercise (derivative) | 3,000 | $0.00 | 3,000 |
| 2022-03-08 | Open-market sale | 3,000 | $73.00 | 0 |
| 2022-03-08 | Option exercise | 3,000 | $10.05 | 3,000 |
| 2022-03-04 | Grant / award (derivative) | 36,000 | $0.00 | 36,000 |
| 2021-11-04 | Option exercise (derivative) | 3,000 | $0.00 | 15,000 |
| 2021-11-04 | Open-market sale | 3,000 | $94.00 | 0 |
| 2021-11-04 | Option exercise | 3,000 | $12.35 | 3,000 |
| 2021-05-18 | Option exercise (derivative) | 3,000 | $0.00 | 6,000 |
| 2021-05-18 | Option exercise (derivative) | 2,000 | $0.00 | 18,000 |
| 2021-05-18 | Open-market sale | 5,000 | $50.75 | 0 |
| 2021-05-18 | Option exercise | 3,000 | $10.05 | 3,000 |
| 2021-05-18 | Option exercise | 2,000 | $12.35 | 5,000 |
| 2021-03-05 | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2021-03-04 | Open-market sale (derivative) | 19,000 | $0.00 | 0 |
| 2021-03-04 | Open-market sale | 19,000 | $44.00 | 0 |
| 2021-03-04 | Option exercise | 19,000 | $6.79 | 19,000 |
| 2020-11-02 | Option exercise (derivative) | 2,094 | $0.00 | 20,000 |
| 2020-11-02 | Open-market sale | 2,094 | $38.74 | 0 |
| 2020-11-02 | Option exercise | 2,094 | $12.35 | 2,094 |
| 2020-08-03 | Option exercise (derivative) | 2,906 | $0.00 | 22,094 |
| 2020-08-03 | Option exercise | 2,906 | $12.35 | 2,906 |
| 2020-08-03 | Open-market sale | 2,906 | $27.91 | 0 |
| 2020-06-05 | Option exercise (derivative) | 6,000 | $0.00 | 9,000 |
| 2020-06-05 | Option exercise | 6,000 | $10.05 | 6,000 |
| 2020-06-05 | Open-market sale | 6,000 | $23.50 | 0 |
| 2018-11-02 | Option exercise (derivative) | 2,500 | $0.00 | 19,000 |
| 2018-11-02 | Open-market sale | 2,500 | $15.71 | 0 |
| 2018-11-02 | Option exercise | 2,500 | $6.79 | 2,500 |
| 2018-10-24 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.